Drugs & Targets eHealth Technologies, CancerX collaborate to accelerate cancer innovation in U.S. June 28, 2024Vol.50 No.26
Drugs & Targets Merck, Qure.ai collaborate to expand lung cancer detection via AI June 28, 2024Vol.50 No.26
Drugs & Targets FDA approves Keytruda combination for primary advanced or recurrent endometrial carcinoma June 21, 2024Vol.50 No.25
Drugs & Targets EMA PRAC identifies risk of secondary malignancies from CAR T-cell medicines June 21, 2024Vol.50 No.25
Drugs & Targets FDA clears IND application for ZW171, a 2+1 T-cell targeting bispecific antibody for mesothelin-expressing cancers June 21, 2024Vol.50 No.25
Drugs & Targets FDA approves Breyanzi for relapsed or refractory mantle cell lymphoma June 14, 2024Vol.50 No.24
Drugs & Targets FDA grants accelerated approval to Augtyro for NTRK gene fusion-positive solid tumors June 14, 2024Vol.50 No.24
Drugs & Targets FDA approves imetelstat for low- to intermediate-1 risk MDS with transfusion-dependent anemia June 07, 2024Vol.50 No.23
